Gaxos.ai Inc

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Gaxos.AI, Inc. develops a digital gaming platform. Its gaming platform offers its proprietary games as well as games developed and published by third parties. The company was founded by Vadim Mats on October 27, 2021 and is headquartered in Roseland, NJ.

Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.

Gaxos Health Expands Medical Advisory Board

Roseland, NJ, March 26, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it received written notice from the NASDAQ Stock Market LLC (NASDAQ) on March 22, 2024, informing the Company that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on the NASDAQ Capital Market.

Gaxos.ai Regains Compliance with Nasdaq Listing Requirements

Roseland, NJ, March 15, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it has closed its previously announced private placement for the purchase and sale of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a purchase price of $5.57 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants have an exercise price of $5.50 per share and are exercisable immediately upon issuance. The series A warrants expire five and one-half years from the date of issuance and short-term series B warrants expire twenty-four months from the date of issuance.

Gaxos.ai Inc. Announces Closing of $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules

Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a purchase price of $5.57 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants, in a private placement priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants will have an exercise price of $5.50 per share and will be exercisable immediately upon issuance. The series A warrants will expire five and one-half years from the date of issuance and the short-term series B warrants will expire twenty-four months from the date of issuance. The private placement is expected to close on or about March 15, 2024, subject to the satisfaction of customary closing conditions.

Gaxos.ai Inc. Announces $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules

Gaxos.ai (NASDAQ: GXAI ) stock is heading higher on Wednesday after the artificial intelligence ( AI ) app company obtained rights to new AI-enabled technology. According to a press release from Gaxos.ai, the company has secured the rights to this AI tech from biohacking app Ultiself.

Why Is Gaxos.ai (GXAI) Stock Up 134% Today?

Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, “Ultiself,” in order to facilitate the development of its tech for Gaxos Health.

Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App

Roseland, NJ, March 06, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it will effect a 1-for-12 reverse split of its issued and outstanding common stock effective as of 4:01pm Eastern Time on March 7, 2024. Commencing with the opening of trading on The Nasdaq Capital Market on March 8, 2024, the Company's common stock will trade on a post-split basis under the same trading symbol, “GXAI”.

Gaxos.ai Inc. Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 8, 2024

Roseland, NJ, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its health and wellness division, Gaxos Health, has formed a medical advisory board for providing invaluable insight into product development and creating strategic opportunities. The Company has appointed Dr. Nate Lebowitz, M.D. as the Chairman of the Advisory Board.

Gaxos Health Forms Medical Advisory Board to Support Launch of AI-powered Health and Wellness Solution

Gaxos.AI (NASDAQ: GXAI ) stock is sliding lower on Tuesday after the non-fungible tokens (NFT) game development and management company's shares saw a major rally on Friday. Shares of GXAI stock closed out Friday up 172.9%.

Why Is Gaxos.AI (GXAI) Stock Down 21% Today?

Roseland, NJ, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its gaming division, Gaxos Gaming, will launch an artificial intelligence (AI) solution for game developers and studios.

Gaxos Gaming to Launch AI Solution for Game Developers and Studios

Roseland, NJ, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications various sectors, today announced a significant strategic expansion with Gaxos Health, a division dedicated to revolutionizing personal health and wellness.

Shareholder Update: Gaxos.AI Expands into AI-powered Health and Wellness Optimization Solutions

Roseland, NJ, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Gaxos.AI ("Gaxos" or the "Company"), today unveils a groundbreaking initiative to revolutionize the world of artificial intelligence. Building on its legacy in gaming, Gaxos is set to launch a visionary suite of artificial intelligence applications, uniquely designed to enhance mental and physical health, combat loneliness, and promote longevity.

UPDATE - Gaxos.AI to Expand with Artificial Intelligence Solutions for Health and Longevity

Roseland, NJ, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Gaxos.AI ("Gaxos" or the "Company"), today unveils a groundbreaking initiative to revolutionize the world of artificial intelligence. Building on its legacy in gaming, Gaxos is set to launch a visionary suite of artificial intelligence applications, uniquely designed to enhance mental and physical health, combat loneliness, and promote longevity.

Gaxos.AI to Expand with Artificial Intelligence Solutions for Health and Longevity

Roseland, NJ, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The NFT Gaming Company, Inc. ("NFTG" or the "Company"), today announced that it has changed its name from NFT Gaming Company to Gaxos.AI and its ticker symbol from “NFTG” to “GXAI”. The Company expects that its shares of common stock will begin trading on The Nasdaq Stock Market under the new name and new stock ticker symbol “GXAI” in January 2024.

NFT Gaming Company Announces Name Change and Ticker Change to Gaxos.AI (GXAI) to focus on Artificial Intelligence

News for Gaxos.ai Inc Stock (GXAI)